HomepageBVNRY • OTCMKTS
add
Bavarian Nordic
Vorige slotkoers
$ 7,82
Dag-range
$ 8,01 - $ 8,08
Jaar-range
$ 6,60 - $ 14,60
Beurswaarde
1,93 mld. USD
Gem. volume
5,24K
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (DKK) | dec 2024info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 2,09 mld. | -14,44% |
Bedrijfskosten | 426,30 mln. | -39,26% |
Netto inkomsten | 770,81 mln. | -14,49% |
Netto winstmarge | 36,81 | -0,05% |
Winst per aandeel | 9,90 | -15,38% |
EBITDA | 936,56 mln. | -7,52% |
Effectief belastingtarief | -3,18% | — |
Balans
Totale activa
Totale passiva
| (DKK) | dec 2024info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 2,18 mld. | 16,44% |
Totale activa | 14,41 mld. | 0,37% |
Totale passiva | 3,00 mld. | -25,32% |
Totaal aandelenvermogen | 11,41 mld. | — |
Uitstaande aandelen | 78,57 mln. | — |
Koers-boekwaardeverhouding | 0,05 | — |
Rendement op activa | 14,59% | — |
Rendement op kapitaal | 18,50% | — |
Kasstroom
Nettomutatie in liquide middelen
| (DKK) | dec 2024info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | 770,81 mln. | -14,49% |
Operationele kasstroom | 955,37 mln. | 63,19% |
Kasstroom uit beleggingen | -325,42 mln. | -126,43% |
Kasstroom uit financiering | -16,92 mln. | -228,06% |
Nettomutatie in liquide middelen | 626,80 mln. | 40,84% |
Vrije kasstroom | -545,47 mln. | -175,59% |
Over
Bavarian Nordic A/S is a fully integrated biotechnology company focused on the development, manufacturing and commercialization of vaccines. The company is headquartered in Hellerup, Denmark, with manufacturing facilities in Kvistgård, Denmark and Thörishaus near Bern, Switzerland. The company has research and development facilities in Martinsried, Germany and San Diego, California, as well as offices in Zug, Switzerland, and Morrisville, North Carolina. The company uses viral vectors and virus-like particles in its research and development. Wikipedia
CEO
Opgericht
1 jul 1992
Website
Werknemers
1.605
